These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8291711)

  • 21. [A case of Farber's disease--histochemical, electron microscopic and biochemical studies].
    Hamanaka S; Hara A; Otsuka F
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):629-34. PubMed ID: 1920894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.
    Samuelsson K; Zetterström R
    Scand J Clin Lab Invest; 1971 Jun; 27(4):393-405. PubMed ID: 5109101
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical diagnosis of a new case of ceramidase deficiency (Farber's disease).
    Cartigny B; Libert J; Fensom AH; Martin JJ; Dhondt JL; Wyart D; Fontaine G; Farriaux JP
    J Inherit Metab Dis; 1985; 8(1):8. PubMed ID: 3921761
    [No Abstract]   [Full Text] [Related]  

  • 24. Farber's disease. Light and electron microscopic study of the eye.
    Zarbin MA; Green WR; Moser HW; Morton SJ
    Arch Ophthalmol; 1985 Jan; 103(1):73-80. PubMed ID: 2983648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Farber's disease as a ceramidosis: clinical, radiological and biochemical aspects.
    Toppet M; Vamos-Hurwitz E; Jonniaux G; Cremer N; Tondeur M; Pelc S
    Acta Paediatr Scand; 1978 Jan; 67(1):113-9. PubMed ID: 626064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease.
    Sugita M; Iwamori M; Evans J; McCluer RH; Dulaney JT; Moser HW
    J Lipid Res; 1974 May; 15(3):223-6. PubMed ID: 4363967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased levels of ceramide in the retina of a patient with Farber's disease.
    Zarbin MA; Green WR; Moser AB; Tiffany C
    Arch Ophthalmol; 1988 Sep; 106(9):1163. PubMed ID: 3415533
    [No Abstract]   [Full Text] [Related]  

  • 28. Farber's disease: a fine structural study.
    Abenoza P; Sibley RK
    Ultrastruct Pathol; 1987; 11(4):397-403. PubMed ID: 3113021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramidase deficiency in Farber's disease (lipogranulomatosis).
    Sugita M; Dulaney JT; Moser HW
    Science; 1972 Dec; 178(4065):1100-2. PubMed ID: 4678225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy.
    Schuchman EH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1459-71. PubMed ID: 27155573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cellular lesions of Farber's disease and their experimental reproduction in tissue culture.
    Rutsaert J; Tondeur M; Vamos-Hurwitz E; Dustin P
    Lab Invest; 1977 May; 36(5):474-80. PubMed ID: 194109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated lipogranulomatosis (Farber's disease).
    ZETTERSTROM R
    Acta Paediatr (Stockh); 1958 Sep; 47(5):501-10. PubMed ID: 13582627
    [No Abstract]   [Full Text] [Related]  

  • 33. [A sphingolipidosis with the accumulation of neutral glycosphingolipids, AO2(GM3) and A1(GM2)-ganglioside (author's transl)].
    Kerènyi L; Kannan R; Gielen W; Debuch H
    Z Klin Chem Klin Biochem; 1974 Nov; 12(11):487-93. PubMed ID: 4216195
    [No Abstract]   [Full Text] [Related]  

  • 34. Farber's disease (disseminated lipogranulomatosis): the first case reported in Japan.
    Ozaki H; Mizutani M; Hayashi H; Oka E; Ohtahara S; Kimoto H; Tanaka T; Hakozaki H; Takahashi K; Suzuki Y
    Acta Med Okayama; 1978 Apr; 32(1):69-79. PubMed ID: 148836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
    Sutrina SL; Chen WW
    Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial lipogranulomatosis (Farber's disease).
    Amirhakimi GH; Haghighi P; Ghalambor MA; Honari S
    Clin Genet; 1976 Jun; 9(6):625-30. PubMed ID: 1277575
    [No Abstract]   [Full Text] [Related]  

  • 37. Anaesthetic management of a child with Farber's lipogranulomatosis posted for exploratory laparotomy.
    Choudhary N; Wadhawan S; Singh R; Bhadoria P
    Indian J Anaesth; 2019 Nov; 63(11):953-955. PubMed ID: 31772410
    [No Abstract]   [Full Text] [Related]  

  • 38. Farber's disease (disseminated lipogranulomatosis)--a pathological, histochemical and ultrastructural study--.
    Tanaka T; Takahashi K; Hakozaki H; Kimoto H; Suzuki Y
    Acta Pathol Jpn; 1979 Jan; 29(1):135-55. PubMed ID: 219658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Farber's disease (lipogranulomatosis).
    Sisson TR
    Am J Dis Child; 1971 Dec; 122(6):513-4. PubMed ID: 5171854
    [No Abstract]   [Full Text] [Related]  

  • 40. [The first diagnosis of Farber's disease in Finland].
    Grönlund J; Salo P; Hällström M; Pohjankoski H; Salo MK
    Duodecim; 2000; 116(15):1555-60. PubMed ID: 12001475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.